AfiSen sp. z o.o.AfiSen is currently engaged in interdisciplinary R&D works focused on sepsis. The resulting innovative solutions, integrating microfluidic, biosensor and bioseparation technologies, will contribute to the development of future personalized, diagnostics-driven therapy aimed at stopping the sepsis process to save patient's life and limit organ damages.